We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
(-18%)
Cap. Flow
-$198M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$9.86M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$9.7M |
| 3 |
CNR
Core Natural Resources Inc
CNR
|
+$8.26M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$6.63M |
| 5 |
Oracle
ORCL
|
+$6.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$14M |
| 2 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$11.1M |
| 3 |
NVIDIA
NVDA
|
+$9.36M |
| 4 |
Amazon
AMZN
|
+$8.75M |
| 5 |
Netflix
NFLX
|
+$8.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.2% |
| 2 | Healthcare | 10.48% |
| 3 | Consumer Discretionary | 9.93% |
| 4 | Financials | 7.26% |
| 5 | Communication Services | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIOA
1076
BioAge Labs
BIOA
$526M
| $65.8K | 0.01% |
17,500
-2,300
| -12% | -$10.6K |
|
1077
Mercer International
MERC
$34.2M
| $64.7K | ﹤0.01% |
+10,527
| New | +$70.7K |
|
|
EB
1078
DELISTED
Eventbrite
EB
| $64.6K | ﹤0.01% |
30,600
-2,700
| -8% | -$8.11K |
|
|
ATYR
1079
aTyr Pharma
ATYR
$51.9M
| $64.4K | ﹤0.01% |
21,318
+11,240
| +112% | +$41K |
|
|
ALMS
1080
Alumis Inc
ALMS
$3.51B
| $64K | ﹤0.01% |
+10,420
| New | +$60.6K |
|
1081
Radiant Logistics
RLGT
$390M
| $64K | ﹤0.01% |
+10,400
| New | +$70.4K |
|
1082
Gilat Satellite Networks
GILT
$832M
| $63.8K | ﹤0.01% |
10,051
-3,029
| -23% | -$21.1K |
|
|
CMPOW
1083
DELISTED
CompoSecure Inc Warrant
CMPOW
| $63.3K | ﹤0.01% |
+16,560
| New | +$73.1K |
|
1084
Real Brokerage
REAX
$466M
| $58.9K | ﹤0.01% |
+14,495
| New | +$68.8K |
|
|
DCH
1085
CALL
Dauch Corp
DCH
$1.58B
| $57.8K | ﹤0.01% |
+14,200
| New | +$72.8K |
|
1086
Energy Fuels
UUUU
$3.57B
| $57.3K | ﹤0.01% |
15,355
-24,597
| -62% | -$118K |
|
1087
Magnachip Semiconductor
MX
$134M
| $57K | ﹤0.01% |
+16,619
| New | +$69.9K |
|
1088
Sensus Healthcare
SRTS
$50.9M
| $56.7K | ﹤0.01% |
11,986
-600
| -5% | -$3.49K |
|
|
QVCGA
1089
DELISTED
QVC Group Inc Series A
QVCGA
| $55.6K | ﹤0.01% |
+5,527
| New | +$87.9K |
|
1090
Relay Therapeutics
RLAY
$4.37B
| $55.5K | ﹤0.01% |
21,200
-275,965
| -93% | -$1.08M |
|
1091
Butterfly Network
BFLY
$2.58B
| $53K | ﹤0.01% |
+23,251
| New | +$83.1K |
|
1092
Nordic American Tanker
NAT
$1.33B
| $51.5K | ﹤0.01% |
+20,954
| New | +$55.2K |
|
1093
American Vanguard Corp
AVD
$65.5M
| $48.7K | ﹤0.01% |
11,059
-17,627
| -61% | -$89.9K |
|
|
TERN
1094
DELISTED
Terns Pharmaceuticals
TERN
| $48.3K | ﹤0.01% |
+17,500
| New | +$71.5K |
|
1095
Identive
INVE
$61.7M
| $48.1K | ﹤0.01% |
15,087
-900
| -6% | -$3.16K |
|
1096
Commercial Vehicle Group
CVGI
$134M
| $46.3K | ﹤0.01% |
40,300
-9,000
| -18% | -$17.4K |
|
1097
Gevo
GEVO
$388M
| $45.7K | ﹤0.01% |
+39,407
| New | +$66K |
|
1098
Shoals Technologies Group
SHLS
$1.44B
| $44.2K | ﹤0.01% |
+13,321
| New | +$55.4K |
|
|
HTT
1099
High Templar Tech Ltd
HTT
$394M
| $43.8K | ﹤0.01% |
+16,271
| New | +$46K |
|
1100
QuantumScape Corp
QS
$3.81B
| $43.1K | ﹤0.01% |
+10,365
| New | +$51.2K |
|
Similar funds
PFBT
SP
HCS
SPC
GPCM
MCM
CC
MB
Prelude Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.
- Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
- Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
- Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
- Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
- Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
- Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
- Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.
Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.